Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001144204-15-046248
Filing Date
2015-08-04
Accepted
2015-08-04 17:57:01
Documents
2
Period of Report
2015-08-03

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v417166_3.html 3  
1 OWNERSHIP DOCUMENT v417166_3.xml 3 1633
2 POWER OF ATTORNEY v417166_ex24.htm EX-24 9382
  Complete submission text file 0001144204-15-046248.txt   12622
Mailing Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211
Business Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211 (310) 358-3200
CAPRICOR THERAPEUTICS, INC. (Issuer) CIK: 0001133869 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CAPRICOR, INC. 8840 WILSHIRE BLVD, 2ND FLOOR BEVERLY HILLS CA 90211
Business Address
Ascheim Deborah (Reporting) CIK: 0001649531 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-34058 | Film No.: 151026796